CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-22 | OYLER JOHN Chief Executive Officer | Sale | −1,772 | $181.79 | $322K | 36,260 |
| 2020-06-22 | OYLER JOHN Chief Executive Officer | Sale | −3,714 | $182.78 | $679K | 32,546 |
| 2020-06-22 | OYLER JOHN Chief Executive Officer | Sale | −3,095 | $183.72 | $569K | 29,451 |
| 2020-06-22 | Wang Xiaodong Director | Sale | −1,800 | $180.37 | $325K | 3,200 |
| 2020-06-22 | Wang Xiaodong Director | Sale | −2,220 | $181.52 | $403K | 980 |
| 2020-06-22 | Wang Xiaodong Director | Sale | −800 | $182.52 | $146K | 180 |
| 2020-06-22 | Wang Xiaodong Director | Sale | −180 | $183.38 | $33K | 0 |
| 2020-06-17 | Chen Timothy Yung-Cheng Director | Grant or award · Share Option (Right to Buy) | +45,383 | 45,383 | ||
| 2020-06-17 | HOOPER ANTHONY C Director | Grant or award · Share Option (Right to Buy) | +45,383 | 45,383 | ||
| 2020-06-17 | Glazer Donald W. Director | Grant or award · Share Option (Right to Buy) | +45,383 | 45,383 | ||
| 2020-06-17 | su Jingshyh S Director | Grant or award · Share Option (Right to Buy) | +45,383 | 45,383 | ||
| 2020-06-17 | Malley Thomas Director | Grant or award · Share Option (Right to Buy) | +45,383 | 45,383 | ||
| 2020-06-17 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +560,599 | 560,599 | ||
| 2020-06-17 | Huang Jane CMO, Hematology | Grant or award | +48,438 | 331,902 | ||
| 2020-06-17 | Huang Jane CMO, Hematology | Grant or award · Share Option (Right to Buy) | +273,286 | 273,286 | ||
| 2020-06-17 | Liang Howard CFO & Chief Strategy Officer | Grant or award | +55,887 | 172,315 | ||
| 2020-06-17 | Liang Howard CFO & Chief Strategy Officer | Grant or award · Share Option (Right to Buy) | +315,341 | 315,341 | ||
| 2020-06-17 | Wu Xiaobin President & GM China | Grant or award | +134,147 | 1,514,562 | ||
| 2020-06-17 | Wu Xiaobin President & GM China | Grant or award · Share Option (Right to Buy) | +756,821 | 756,821 | ||
| 2020-06-17 | OYLER JOHN Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +1,821,976 | 1,821,976 |
Page 93 of 99 · 1,972 trades